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Alterations in Antigenic Properties of Normal Epidermis Adjacent to 
Basal Cell Carcinomas 
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Department of Dermatology, New York University School of Medicine, New YOI'll, New YOI'll, U.S.A. 
The expression of U-CYT antigens, tissue-specific cy-
toplasmic antigens of keratinocytes that are markers of 
the terminal differentiation of these cells, was studied in 
normal skin adjacent to malignant epidermal tumors. 
Ten basal-cell carcinomas were studied. In all cases, it 
was found that the expression of U-CYT antigens in 
normal epidermis gradually decreased with increasing 
proximity to the tumors and finally disappeared com-
pletely within the tumor tissue itself. This finding sug-
gests that basal-cell carcinoma can alter the normal 
differentiation of adjacent nonmalignant cells. 
There are several types of tissue-specific antigens in the 
cytoplasm of normal huma n keratinocytes [1]. Two of these, 
the upper cytoplasmic antigens (U-CYT) and basal cell layer 
antigens (BCL) antigens, are markers of epidermal differentia-
tion. They are expressed in differ ent populations of cells which 
are stratified in distinct layers of the epidermis [2,3]. The U-
CYT antigens are expressed only in t he upper layer s of the 
epidermis [4,6] , whereas BCL a ntige ns are present only in the 
basal cell layers [7,8]. Both antigens a lso appear to be markers 
of malignant transformation. They are lost or greatly decreased 
in expression in malignant basal- and sq uamous-cell carcinomas 
of the skin but are retained in benign tumors of the skin [2]. 
Control studies have shown this change is not due to alterations 
in the morphological appearance or growth r ate ofkeratinocytes 
[3]. 
During the course of these studies it was also observed that 
on occasion the expr ession of U -CYT antigens was decreased in 
normal skin overlying malignant lesions [2], suggesting that 
changes in the antigenic co mposition of cells could precede 
malignant transformation. Because such a phenomenon would 
have important implications on our understa nding of tumor 
progression, we have now systematically studied the expression 
of U-CYT a ntigens in normal skin adjacent to cutaneous malig-
na ncies. The results confirm that U-CYT antigens are lost in 
malignant tissue, and indicate that the expression of these 
antige ns is also partially decreased in appal'ently normal skin 
immediately adjacent to basal-cell carcinomas. 
MATERIALS AND METHODS 
Antisera 
Three human sera containing antibodies to U-CYT antigens were 
obtained, as previously described [3]. The titer of U-CYT antibodies 
ranged from 1/ 20 to 1/ 64. These sera contained antibodies that by 
indirect immuno!1uorescence reacted to antigens expressed only in the 
·c.Ytoplasm of keratinocytes in the superficial layers of the epidermis, 
and did not react to a variety of unrelated human ce lls, including 
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spleen, liver, brain, and (;O lon [3]. These sera, as we ll as normal human 
serum lacking CYT antibodies, were aliquoted and sto red at -30 D C. 
For use, the sera were diluted 1/2 and 1/5 in phosphate buffer saline 
(PBS), pH 7.2. 
Tissues 
Specimens of tumor tissue and surrounding normal skin were ob-
tained by surgical excision from 10 basal-cell carcinomas. The clinical 
features of the specimens are summarized in Table l. T he specimens 
were immediately frozen in liquid nitrogen and stored for no longer 
than 5 days at - 30D C. For use, the specimens were embedded in OCT 
compound (Tissue T ek, Ames Co., E lkhart, Ind.) and cut in 4 p. sections 
on a cryostat. Presence of tumor was confirmed by histological exami-
nation in all cases. 
Conjugate 
Fluorescein-labeled goat ant ihuman IgG was purchased from Hyland 
Co. (Costa Mesa, Cal. ). It reacted specifica lly to human IgG by immu-
noelectrophoresis. The protein concent ration wa 24 mg/ ml, the anti-
body content 1.6 mg/ ml, the l1uorescein isothiocyanate concentrat ion 
0.166 mg/ml, and the l1uorescein to protein ratio 6.9 mg/ gm. For use, 
the conjugate was dilu ted 1/20 in PBS, i.e., 50 p.g/ ml antibody content. 
TABLE l. Clinical feature:; of basal cell carcin.om.as 
S pecimen Duration Primary 01' Size (mo) recurren t" (em ) 
8869 5-6 P 1 X 1 
8956 unk P unk 
9004 48 P 2x2 
9029 48 P 1.5 X 1.5 
10843 6 P 8 x.6 
10854 18 P I X 1 
8888 18 R I X 1 
8997 72 R 5X4 
9850 unk R 2 X 2 
9005 8 R 1 X 1.2 
" P-primary tumor; R-recurrent tumor; unk-unknown. 
Im.munoflu.orescence Test 
Indirect immunol1uorescence was performed by a standard tech-
nique, the deta ils of which have been previously described [91, All 
specimens were reacted to the 3 sera containing U-CYT an tibodies as 
well as with normal human serum. Slides were examined with a Zeiss 
binocu lar microscope equipped fo r transmission flu orescence wit.h an 
HBO 200 mercury vapor lamp and Zeiss FITC exciter and "50" barrier 
fil te rs. Cri te ria for int.erpreting epidermal cytoplasmic antibodies have 
been published [9]. Brie!1y, they were defined as: (l) !1uorescence of 
the cytoplasm of epidennal ce lls that was distinctly brighter than that 
of the underlying dennis, and (2) distinctly visible nonf1uoresc ing nuclei 
and in tercellular spaces. Th e in tensity of !1uorescence was graded on a 
0-3+ scale to provide a semiquantitative estimate of the amount of 
antigen expression in tissue. When necessary, sections were also stained 
with acrid ine orange [101 to facilitate the location of tumor cells by 
darkfie ld microscopy. 
RESULTS 
The prese nce of U -CYT antigens in normal skin, as visualized 
by indirect immunofluoresce nt, is illustrated in Fig lA o It can 
be seen that the antigens are expressed solely in the cytoplasm 
of keratinocytes and that there is no antigen expression in 
nuclei or in tercellular spaces which appear as dark unstained 
areas. 
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FlO 1. A, Appearance by indirect immunoOuorescence of U-CYT 
antigens in the cytoplasm of t he ke ra tinocytes in t he superficial layers 
of the epidermis. Note th at the Ouorescence is rest ricted to t he cyto-
plasm of the ce lls. There is no Ouorescence of nucle i or in terce llular 
spaces which appear as dark, unstained areas, or of ce lls in the lower 
layers of the epidermis. B, Normal control demonstrating lack of 
cytoplasmic Ouorescence when normal human serum is reacted with 
normal human skin (reduced from x 500). 
TABLE II. Expression of U-CYT antigens in normal and tu.mor 
tissu.es 
Expression of U-CYT a ntigens normal tissue 
Specimen Immediately Tumor Distal from 
adjace nt to tissue tumor tumor 
8869 1+ 0-1+ 0 
8956 2+ 0-1+ 0 
9004 2+ 0-1+ 0 
9029 1-2+ 0 0 
10843 2- 3+ 0-1+ 0 
10854 2-3+ 0-1+ 0 
8888 2+ 0-1+ 0 
8950 3+ 0-1+ 0 
8997 2+ 0-1+ 0 
9005 2+ 1+ 0 
The expression of U -CYT antigens in basal-cell carcinomas 
and adjacent normal epidermis is summarized in Table II. U-
CYT antigens were not detected in tumor tissue in any of the 
the 10 basal-cell carcinomas studied (Fig 2B). The loss was not 
due to the absence of U-CYT antigens in the patients studied, 
since in all cases the antigens were present in normal skin 
several millimeters away from tumor tissue (see Fig 2A). Of 
more interest was that the expression of U-CYT a ntigens was 
also markedly decreased in normal epidermis immediately ad-
jacent to tumor tissue (see Fig 2B) . This decrease was the result 
of a gradual process that began in normal skin within 1 to 2 
mm from tumors and became most marked immediately adja-
cent to tumor tissue. A gradual decrease in the expression of U-
CYT antigens in normal skin adjacent to cutaneous tumors was 
observed in all the specimens studied. The extent of this zo ne 
F I G 2. Expression of U-CYT antigens in norma l skin; A, d istal to 
and B, immediate ly adjacen t to basal-ce ll carc inoma. Note that st.aining 
of U-CYT a ntigens is much less pronounced in the norma l epidermis 
immediate ly adjacent to tumor t issue than in the distal specimen a nd 
that U-CYT antigens ar e complete ly lacking in tumor t issue (*) vis ible 
in specimen B. Nonspecific staining of th e dermis is s imilar in both 
cases, indicating that the decreased staining 'of U-CYT a ntige ns is not 
due to change in exposure time or ligh t in tensity (reduced from X 312). 
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did not appear to correlate to the size or duration of the tumor, 
nor to whether the tumor was primary or recurrent. Similar 
results were obtained with 3 different antisera to U-CYT anti-
gens. 
DISCUSSION 
The results of this study indicate that the expression of some 
normal antigens of human keratinocytes, i.e., the U-CYT anti-
gens, is decreased in a zone of normal epidermis adjacent to 
basal-cell carcinomas. The decrease is gradual. It becomes 
progressively more pronounced with increasing proximity to 
tumor tissue, and eventuates in complete loss of antigen in 
morphologically transformed cells. 
U -CYT antigens are one of several tissue-specific antigens of 
normal human keratinocytes [2,3). They are expressed in all 
normal individuals which have been studied to date [3). They 
are markers of terminal differentiation of keratinocytes since 
they are expressed only in cells of the superficial layers of t he 
ep idermis [3,11)' U-CYT antigens are greatly decreased in 
expression or completely absent in all basal- and sq uamous-cell 
carcinomas which have been studied to date [2,3). T he antigens, 
however, remain fully expressed in benign tumors of the skin 
[3] even in instances such as keratoacanthomas wh ere the 
morphological appearance of the cells is often indistinguishable 
[12] from that of malignant cells. The antigen loss is unrelated 
to changes in the growth rate of keratinocytes, since U-CYT 
antigens are fu lly expressed in psoriasis, a disease where epi-
dermal turnover is much faster than in basal- or squamous-cell 
carcinomas [13,14)' It is of interest that G-CYT antigens, an-
other class of cytoplasmic antigens which is expressed in epi-
dermal cells in all layers of the epidermis including the basal 
layer, and is thus not a marker for the terminal differentiation 
of ke ratinocytes, remains fully expressed in basal- and squa-
mous-cell carcinomas [2,3)' Thus, it is unlikely that the inability 
to demonstrate U-CYT antigens in tumor tissue is due to an 
artifact of the assay such as the inability of specific antiserum 
or conjugate to diffuse into the tissue . 
U -CYT antigens are one of several normal epidermal antigens 
whose expression is markedly decreased or completely abol-
ished in malignant skin tumors. Thus, antigens in the intercel-
lular substance and in the basement zone of normal epidermis 
are also lost in basal- and-squamous cell carcinomas of the skin 
[15-17]' ABO blood group antigens are lost in malignant tumors 
arising from the epithelium of the bladder [20], oral mucosa 
[18], 13.1·ynx [19], and cervix [21] including carcinoma in situ 
[21). Loss of normal t issue antigens in transformed cells is a 
well known phenomenon [22] which reflects the loss of differ-
entiated properties which accompanies malignant transforma-
tion. The novel observation made in this study is that the 
expression of normal tissue antigens may also decrease consist-
ently in morphologically normal cells adjacent to tumors. Loss 
of ABO blood group antigens in normal epithelium adjacent to 
squamous-cell c3.1·cinomas of the oral cavity has been previously 
described in 2 patients [18,19). 
The reasons for the decreased expression of U-CYT antigens 
. in normal skin around tumors was not elicited, but the find ing 
is open to several interpretions. The most likely is that diffusible 
factors elaborated by malignant cells interfere with the normal 
differentiation of adjacent normal cells. This would explain the 
gradual loss of U-CYT antigens with ·increasing proximity to 
tumor tissue. Alternatively, infe.ctious oncogenic agents released 
by tumor cells could have a similar effect since viral infections 
of cells can alter the pattern of antigens they express [23). 
Lastly, the acquisition of a phenotypic alteration seen in malig-
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nancy by cells which ar e otherwise normal morphologically is 
consistent with an old concept of tumor progression proposed 
by Willis [24] and Brunschwig [25] that neoplasms may in part 
progress by the gradual transformation of normal cells into 
malignant cells. 
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